Tai Chi improves antioxidant and anti-inflammatory abilities via the KEAP1-NRF2 pathway in peripheral blood leukocytes of lung cancer patients: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032168

Enrollment

Unknown

Registered

2020-04-22

Start date

2016-04-18

Completion date

Unknown

Last updated

2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

control group:normal exercise

intervention group:Tai Chi

Eligibility

Sex/Gender

All

Age

18 Years to 89 Years

Inclusion criteria

Inclusion criteria: According to the diagnostic criteria of the Chinese Medical Association Respiratory Diseases Branch, patients with non-small cell lung cancer (NSCLC) and surgical conditions; patients aged more than 18 years; no routine examinations after admission, no abnormalities Stable, no obvious heart and liver and kidney and other important organs serious underlying diseases; preoperative pulmonary function tests without obvious ventilatory disorders; no mental and central nervous system symptoms.

Exclusion criteria

Exclusion criteria: The patients received chemoradiotherapy within 6 months prior to lung surgery. Intraoperative and postoperative tracheal intubation time > 24 h, or postoperative transfer. Those who have dropped out in time will replenish the sample size in time.

Design outcomes

Primary

Measure	Time frame
Lung function;	—

Countries

China

Contacts

Public ContactJin Liying

The First Hospital of Jilin University

jinliying6@126.com+86 18186878801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026